Our Sept. Covid-19 Update for You

Greetings! 
We took a short break from our weekly newsletters to you; however, we thought it’s time to provide you with some current valuable information on COVID-19 and our response to it. 

---

• We have enhanced our robust sanitizing practices to keep you safe. 
• We have changed protocols to avoid crowding in the reception room and inside the entire office.
• Everyone entering the office is screened for symptoms of COVID-19 infection. 
• ​Everyone is encouraged to arrive alone, unless a caregiver or other person is necessary to accompany you. 
• Employees are instructed to stay home if they don’t feel well. 
• To protect others, we have a separate back entrance for patients if there is any suggestion of having COVID-19 and they are taken to a negative pressure room to avoid transmission to others. 
• Facial coverings and social distancing are required of everyone. 
• We have the Rapid 15-minute COVID-19 test, and this has proven to be very useful for us.

Postponing your heath care is no longer recommended. We are doing whatever we can to keep you safe. Additionally, telemedical visits are still available when appropriate.

Over the past 30 years, many of our patients have participated in clinical trials at our clinic. We have maintained a separate research center, with an exceptional staff and a reputation of excellence.   Dr. Benson is a certified research professional (CRP) from the Society of Clinical Research Associates (SOCRA). We are proud to announce that the Be Well Medical Center has been selected as one of one hundred sites (70 in the USA) for an international phase 3 Clinical trial to evaluate the efficacy and safety of Remdesivir for COVID-19 in the outpatient setting.
 
Currently, Remdesivir has been approved by emergency use authorization to treat COVID-19 infected patients inside the hospital when symptoms are moderate or severe. Specialists we refer to, familiar with using Remdesivir In hospitalized patients, report success when using this medication compared to COVID-19 care before it became available. Our study will evaluate approximately 1230 participants in the outpatient setting with milder symptoms not requiring hospitalization. 

With earlier use of Remdesivir, we are hoping to prevent disease progression. This may reduce hospitalizations, improve survival, and result in less burden to healthcare systems. We are very excited about being included in this trial and to be at the cutting edge of COVID-19 care.

If you have recovered from COVID-19 and are interested in donating your plasma to potentially help others, please use the following link to learn more including local centers you can use. The link is https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/donate-covid-19-plasma

Here are 4 simple things you can do now to protect yourself now:

1. Wear facial coverings
2. Maintain social distancing
3. Wash your hands often with soap and water
4. Be smart about being in groups of people

To Your Good Health We Remain